(MSSV:OTC). As part of the transaction, Lans will transfer over its LOI with Global Stem Cells Group to MSSV and in exchange, MSSV will take on Lans debt and will give Lans redeemable preferred shares that convert into a number of common shares of MSSV equal to outstanding shares times 0.8. Please read this in conjunction with the 8K's filed with the SEC by MSSV on November 27th, 2019